Twist Bioscience (NASDAQ:TWST – Free Report) had its price target boosted by Evercore ISI from $46.00 to $50.00 in a report issued on Friday morning, Benzinga reports. Evercore ISI currently has an outperform rating on the stock. Several other brokerages also recently issued reports on TWST. Robert W. Baird lifted their price objective on Twist […]
Twist Bioscience (NASDAQ:TWST – Get Free Report) had its price target lifted by Scotiabank from $43.00 to $48.00 in a report released on Monday, Benzinga reports. The brokerage presently has a “sector outperform” rating on the stock. Scotiabank’s price objective would indicate a potential upside of 7.43% from the company’s current price. Several other equities […]
Twist Bioscience (NASDAQ:TWST – Get Free Report) had its price objective hoisted by investment analysts at Evercore ISI from $46.00 to $50.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm currently has an “outperform” rating on the stock. Evercore ISI’s target price would indicate a potential upside of […]
Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) COO Patrick John Finn sold 2,174 shares of the firm’s stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $30.12, for a total value of $65,480.88. Following the sale, the chief operating officer now owns 176,206 shares […]
Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) COO Patrick John Finn sold 2,174 shares of the business’s stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $30.12, for a total transaction of $65,480.88. Following the completion of the sale, the chief operating officer now directly owns […]